While PERK-mRNA levels remained constant in all treatment conditions, we found that combining DOX with 4μ8C reduced ATF4 and CHOP-levels compared to untreated HCC levels (Figure 4E and F). The gene discussed is ATF4; the disease is hepatocellular carcinoma.